Epigenetic reprogramming as a key to reverse ageing and increase longevity
Ageing Research Reviews · 2024-03 · 95 · 102204
DOI: 10.1016/j.arr.2024.102204 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2024-03. Verfasst von Beatriz Pereira und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Aveiro, Aveiro, Portugal. Hauptthemen laut MEDLINE: Longevity, DNA Methylation. Die Arbeit wurde bisher 109-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministério da Ciência, Tecnologia e Inovação, European Regional Development Fund, Universidade de Aveiro.
Abstract (Originalsprache)
The pursuit for the fountain of youth has long been a fascination amongst scientists and humanity. Ageing is broadly characterized by a cellular decline with increased susceptibility to age-related diseases, being intimately associated with epigenetic modifications. Recently, reprogramming-induced rejuvenation strategies have begun to greatly alter longevity research not only to tackle age-related defects but also to possibly reverse the cellular ageing process. Hence, in this review, we highlight the major epigenetic changes during ageing and the state-of-art of the current emerging epigenetic reprogramming strategies leveraging on transcription factors. Notably, partial reprogramming enables the resetting of the ageing clock without erasing cellular identity. Promising chemical-based rejuvenation strategies harnessing small molecules, including DNA methyltransferase and histone deacetylase inhibitors are also discussed. Moreover, in parallel to longevity interventions, the foundations of epigenetic clocks for accurate ageing assessment and evaluation of reprogramming approaches are briefly presented. Going further, with such scientific breakthroughs, we are witnessing a rise in the longevity biotech industry aiming to extend the health span and ideally achieve human rejuvenation one day. In this context, we overview the main scenarios proposed for the future of the socio-economic and ethical challenges associated with such an emerging field. Ultimately, this review aims to inspire future research on interventions that promote healthy ageing for all.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry, University of Aveiro, Aveiro, Portugal.
- LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Aveiro, Portugal.
- LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Aveiro, Portugal. Electronic address: jorgesaraiva@ua.pt.
Förderung
- Ministério da Ciência, Tecnologia e Inovação
- European Regional Development Fund
- Universidade de Aveiro
- Fundação para a Ciência e a Tecnologia
Zitieren
APA
Pereira, B., Correia, F. P., Alves, I. A., Costa, M., Gameiro, M., Martins, A. P., & Saraiva, J. A. (2024). Epigenetic reprogramming as a key to reverse ageing and increase longevity. Ageing Research Reviews, 95, 102204. https://doi.org/10.1016/j.arr.2024.102204
Vancouver
Pereira B, Correia FP, Alves IA, Costa M, Gameiro M, Martins AP, et al. Epigenetic reprogramming as a key to reverse ageing and increase longevity. Ageing Research Reviews. 2024;95:102204. doi:10.1016/j.arr.2024.102204
BibTeX
@article{Pereira2024,
author = {Pereira, Beatriz and Correia, Francisca P and Alves, Inês A and Costa, Margarida and Gameiro, Mariana and Martins, Ana P and Saraiva, Jorge A},
title = {Epigenetic reprogramming as a key to reverse ageing and increase longevity},
journal = {Ageing Research Reviews},
year = {2024},
volume = {95},
pages = {102204},
doi = {10.1016/j.arr.2024.102204}
}
EUVIMED